Navigation Links
Dana Farber/Harvard Cancer Center awarded $11.7M grant to support prostate cancer research
Date:12/27/2010

BOSTON--Dana Farber/Harvard Cancer Center (DF/HCC) will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation (PCF).

Judge Richard G. Stearns of the United States District Court for the District of Massachusetts awarded DF/HCC approximately $11.7 million in a cy pres ("near as possible") distribution of unclaimed funds from the settlement of a nationwide class action involving the marketing of the cancer drug Lupron(R). Judge Stearns made the award to DF/HCC after reviewing a number of proposals solicited from class members and the public.

The DF/HCC grant program will emphasize large-scale research collaborations on a national level and smaller-scale innovative pilot projects as well as research conducted by promising young investigators and talented graduate students. The goal is to catalyze innovative and collaborative research that will translate to meaningful clinical advances for prostate cancer patients and others.

"It is our vision that this program will further our scientific and clinical understanding of prostate cancer, lead to better and new treatments, and provide critical funds to young investigators to help them develop into the next generation of prostate cancer researchers," said Philip Kantoff, M.D, director of DF/HCC prostate cancer program.

Under the direction of Kantoff, who also leads the prostate cancer program at Dana-Farber Cancer Institute, the A. David Mazzone Awards Program will primarily fund research in the causes of prostate cancer as well as research in other diseases, like precocious puberty, for which Lupron has proven an effective treatment. The program leverages existing DF/HCC infrastructure and funding mechanisms, as well as a longstanding, collaborative relationship with PCF. DF/HCC and PCF will each administer research funds through their respective competitive grant programs. A call for applications is expected to occur in early 2011.


'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Related medicine news :

1. Gene Mutation Found in One of Four Cases of Deadly Brain Cancers
2. Penn researchers identify potential target for breast cancer therapy
3. Cancer Cells May Be Able to Urge Their Own Death
4. Recurrence of Oral Cancer Found to Signal Poor Outcome
5. Age plays too big a role in prostate cancer treatment decisions
6. UH biochemist works to revolutionize ovarian cancer treatment
7. Smoking may worsen pain for cancer patients
8. Tumor cells in blood may signal worse prognosis in head and neck cancer patients
9. Factors linked to speech/swallowing problems after treatment for head and neck cancers
10. Blacks with liver cancer more likely to die, study finds
11. Robotic surgery for head and neck cancer shows promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... 24, 2017 , ... Accordant Technology, a trusted IT solutions ... an analytics-first approach, layered with machine learning, that provides real-time visibility into the ... cloud to the edge. Through the new partnership, customers get the real-time situational ...
(Date:5/24/2017)... ... May 24, 2017 , ... Fiberstar, Inc., ... the food and beverage industry offers Citri-Fi®, a natural citrus fiber, to improve ... decision process. As a result, labels need to deliver simple, transparent and clear ...
(Date:5/23/2017)... , ... May 23, 2017 , ... Allegheny Health ... open The Alexis Joy D’Achille Center for Women’s Behavioral Health at West Penn ... in western Pennsylvania for women suffering from pregnancy-related depression. Construction of the Center ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... body for exercise professionals, is pleased to announce the organization’s Certified Strength Coach ... The NCSF Certified Strength Coach (CSC) program validates the competency of qualified candidates ...
(Date:5/23/2017)... York (PRWEB) , ... May 23, 2017 , ... ... LifeLabs, a leading equipment provider in the modern ART laboratory, to provide hands-on ... in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing vendor ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/11/2017)... , May 11, 2017  Thornhill Research ... has been awarded an $8,049,024 USD five-year, firm-fixed-priced, ... through the Canadian Commercial Corporation (CCC) ( ... Anesthesia Systems to administer general anesthesia to patients ... "The US Marine Corps have been ...
(Date:5/10/2017)... May 10, 2017 Radiology has become the ... costs have also spiraled to the number one ranking ... radiology than ever before as the most complete and ... patient with lower back pain an MRI may confirm ... for pain, resulting in entirely different treatment protocols.  In ...
Breaking Medicine Technology: